<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Inborn errors of purine-pyrimidine metabolism / Uric acid / Chemistry / Pegloticase / Gout / Hyperuricemia / Savient pharmaceuticals / Urate oxidase / Allopurinol / Allantoin
Date: 2016-07-11 17:00:34
Medicine
Clinical medicine
Inborn errors of purine-pyrimidine metabolism
Uric acid
Chemistry
Pegloticase
Gout
Hyperuricemia
Savient pharmaceuticals
Urate oxidase
Allopurinol
Allantoin

Microsoft Word - puricase-Phase I-ivpress release.doc

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 28,79 KB

Share Document on Facebook

Similar Documents

Medicine / Biotechnology / PEGylation / Pharmacokinetics / Pegloticase / Savient pharmaceuticals / Biology / Health / Urate oxidase / Gout / Uric acid / Pharmaceutical industry in China

Microsoft Word - Savient Phase 3 Dosing press releasedoc

DocID: 1ri7E - View Document

Medicine / Health care / Health / Rheumatology / Inborn errors of purine-pyrimidine metabolism / Uric acid / Pegloticase / Savient pharmaceuticals / Gout / Tophus / Hyperuricemia / Clinical trial

Microsoft Word - Savient press release re ACRdoc

DocID: 1reUR - View Document

Medical research / Pharmacology / Health / Food and Drug Administration / Pharmaceutical industry / Clinical research / Drug discovery / PEGylation / Pharmacokinetics / Savient pharmaceuticals / Pegloticase / FDA Special Protocol Assessment

Microsoft Word - Savient press release Puricase SPAdoc

DocID: 1qW9f - View Document

Medicine / Clinical medicine / Inborn errors of purine-pyrimidine metabolism / Uric acid / Chemistry / Pegloticase / Gout / Hyperuricemia / Savient pharmaceuticals / Urate oxidase / Allopurinol / Allantoin

Microsoft Word - puricase-Phase I-ivpress release.doc

DocID: 1qOjy - View Document

Medicine / Health / Medical research / Pegloticase / Savient pharmaceuticals / PEGylation / Gout / Uric acid / Clinical trial

Microsoft Word - Savient Reports Positive Top-Line Resultsdoc

DocID: 1qCIQ - View Document